The role of lysophosphatidic acid on human osteoblast formation, maturation and the implications for bone health and disease

This publication has 92 references indexed in Scilit:

• Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites
  Kidney International, 2012
• LPA-induced suppression of periostin in human osteosarcoma cells is mediated by the LPA1/Egr-1 axis
  Biochimie, 2012
• Controlling cancer through the autotaxin–lysophosphatidic acid receptor axis
  Biochemical Society Transactions, 2012
• Effects of 25-hydroxyvitamin D3 on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α-hydroxylase
  Journal of Bone and Mineral Research, 2010
• Lysyl Oxidase (Lox) Gene Deficiency Affects Osteoblastic Phenotype
  Calcified Tissue International, 2009
• Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo
  Biochemical Journal, 2009
• Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators
  Current Opinion in Cell Biology, 2008
• Phosphatase-resistant analogues of lysophosphatidic acid: Agonists promote healing, antagonists and autotaxin inhibitors treat cancer
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
• The ins and outs of lysophosphatidic acid signaling
  BioEssays, 2004
• The emerging role of lysophosphatidic acid in cancer
  Nature Reviews Cancer, 2003